T cell antigen receptor stimulation induces MALT1 paracaspase - Mediated cleavage of the NF-κB inhibitor A20

Nature Immunology

Volumn 9, Issue 3, 2008, Pages 263-271

  Coornaert, Beatrice ^a,b   Baens, Mathijs ^b,c   Heyninck, Karen ^a,b   Bekaert, Tine ^a,b   Haegman, Mira ^a,b   Staal, Jens ^a,b   Sun, Lijun ^d   Chen, Zhijian J ^d   Marynen, Peter ^b,c   Beyaert, Rudi ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; APOPTOSIS INHIBITOR 2; ARGININE; CASPASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCOSA ASSOCIATED LYMPHOID TISSUE PROTEIN 1; PROTEIN BCL 10; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN A20;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

CASPASES; CELL LINE; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NEOPLASM PROTEINS; NF-KAPPA B; NUCLEAR PROTEINS; PEPTIDE HYDROLASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 39449131430     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1561     Document Type: Article

References (39)

1. Matsumoto, R. et al. Phosphorylation of CARMA1 plays a critical role in T cell receptor mediated NF-κB activation. Immunity 23 575-585 (2005).
2. Sommer, K. et al. Phosphorylatioa of the CARMA1 linker controls NF-κB activation. Immunity 23, 561-574 (2005).
3. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001).
4. Ruland, J., Duncan, G.S., Wakeham, A. & Mak, T.W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749-758 (2003).
5. Ruefli-Brasse, A.A., French, D.M. & Dixit, V.M. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581-1584 (2003).
6. Ferch, U. et al. MALT1 difects B cell receptor-induced canonical nuclear factor-κB signaling selectively to the c-Bel subunit. Nat. Immunol. 8, 984-991 (2007).
7. Zhang, Q. et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22, 63-68 (1999).
8. Willis, T.G. et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96 35-45 (1999).
9. Dierlamm, J. et al. The apoptosis inhibitor gene APL2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11.;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93, 3601-3609 (1999).
10. Sanchez-Izquierdo, D. et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101, 4539-4546 (2003).
11. Zhou, H. et al. Bcl10 activates the NfκB pathway through ubiquitination of NEMO Nature 427, 167-171 (2004)
12. Uren, A.G. et al. Identification of paranaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6, 961-967 (2000).
13. Sun, L., Deng, L., Ea, C.K., Xia, Z.P. & Chen 2.1 The TRAF6 ubiquitiin ligase and TAK1 kinase mediate IKK activation-by BCl10 and MALT1 in T lymphocytes. Mol Cell 14, 289-301 (2004).
14. Lucas, P.C. et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-κB signalling pathway, J. Biol, Chem. 276. 19012-19019 (2001).
15. Beyaert, R., Heyninck, K. & Van Huffel; S. A20 and A20 binding as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143-1151 (2000).
16. Lee, E.G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350-2354 (2000).
17. Tewari, M. et al Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J. Immunol. 154, 1699-1706 (1995).
18. Sun, Z. et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404 402-407 (2000).
19. Wang, D. et al. A requirement for CARMA1 in TCR-induced NF-κB activation. Nat. Immunol. 3, 830-835 (2002).
20. Su, T.T. et al. PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3 780-786 (2002).
21. Egawa, T. et al. Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation. Curr. Biol. 13, 1252-1258 (2003).
22. Snipas, S.J., et al. Characteristics of the caspase-like catalytic domain of human paracaspase. Biol. Chem. 385, 1093-1098 (2004).
23. Earnshaw, W.C., Martins, L.M. & Kaufmann, S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annnu. Rev. Biochem. 68, 383-424 (1999).
24. Vercammen, D. et al. Type metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine. J. Biol. Chem. 279, 45329-45336 (2004).
25. Wertz, I.E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004).
26. Boone, D.L. et al. The ubiquitin-modifying enzyme A20 is required for termination of T0ll-like receptor responses. Nat. Immunol. 5, 1052-1060 (2004).
27. Boatright, K.M. et al. A unified model for apical caspase activation. Mol. Cell 11, 529-541 (2003).
28. Heyninck, K. & Beyaert, R. A20 inhibits NF-κB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1-4 (2005).
29. Mauro, C. et al. ABIN-1 binds to NEMO/IKKgamma and co-operates With A20 in inhibiting NF-κB. J. Biol. Chem. 281, 18482-18488 (2006).
30. Klinkenberg, M., Van Huffel, S., Heyninck, K. & Beyaert, R. Functional redundancy of the zinc fingers at A20 for inhibition of NF-κB activation and protein-protein interactions. FEBS Lett. 498, 93-97 (2001).
31. Dykstra, M., Cherukuri, A., Sohn, H.W., Tzeng, S.J. & Pierce, S.K. Loaation is everything: Lipid rafts and immune cell signalling. Annu. Rev. Immunol. 21, 457-481 (2003).
32. Gaide, O. et al. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nat. Immunol. 3, 836-843 (2002).
33. L associate in lipid rafts with NF-κB adaptors during-T cell activation. J. Biol. Chem. 282, 19365-19374 (2007).
34. Noels, H. et al. A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by APL2MALT1-fusions. J. Biol. Chem. 282, 10180-10189 (2007).
35. McAllistet-Lucas, L.M. et al. CARMA3/Bcl10/MALT1-dependent NF-κB activation mediates angiotensin II-responsive inflammatory signalling in nonimmune cells. Proc. Natl. Acad. Sci. USA 104, 139-144 (2007).
36. Klemm, S., Zimmermann, S., Peschel, C., Mak, T.W. & Ruland, J. Bcl10 and Malt1 control lysophosphatidic acid-induced NF-κB activation and cytokine production: Proc. Natl Acad. Sci. USA 104, 134-138 (2007).
37. Klemm, S. et al. The Bcl10-Malt1 complex segregates FcεRI-mediated nuclear factor κB activation and cytokine production from mast cell degranulation. J. Exp. Med. 203, 337-347 (2006).
38. Gross, O. et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006).
39. Heyninck, K. et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-Inhibiting protein ABIN. J. Cell Biol. 145, 1471-1482 (1999).